Home > Boards > US Listed > Biotechs > Puma Biotechnology, Inc. (PBYI)

PBYI buy 85.80

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stocktrademan Member Profile
 
Followed By 461
Posts 9,985
Boards Moderated 1
Alias Born 04/28/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2020 4:16:46 PM
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results Business Wire - 2/20/2020 4:07:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 4:11:57 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 12:02:09 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/13/2020 12:24:28 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 6:11:57 AM
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 2/7/2020 4:55:00 PM
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2019 Financial Results Business Wire - 2/5/2020 4:15:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2020 12:18:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/4/2020 5:42:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/4/2020 5:38:21 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/3/2020 4:55:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/13/2020 7:32:33 AM
Puma Biotechnology Releases Slides to be Presented at the J.P. Morgan Healthcare Conference Business Wire - 1/13/2020 7:30:00 AM
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 1/9/2020 5:15:00 PM
Puma Biotechnology to Present at the J.P. Morgan Healthcare Conference Business Wire - 1/7/2020 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 5:15:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 4:48:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 4:33:26 PM
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 12/16/2019 5:55:00 PM
Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Pos... Business Wire - 12/13/2019 6:00:00 PM
plasmaMATCH Trial Shows Neratinib Activity in ERBB2 (HER2) Mutant Metastatic Breast Cancer Business Wire - 12/12/2019 12:30:00 PM
Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, ... Business Wire - 12/11/2019 6:03:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/3/2019 4:52:23 PM
Puma Biotechnology Licensing Partner Specialised Therapeutics Receives Marketing Approval in Singapore for NERLYNX® (neratin... Business Wire - 12/2/2019 4:30:00 PM
stocktrademan   Sunday, 08/06/17 12:29:32 PM
Re: None
Post # of 152 
PBYI buy 85.80

double bottom
others might interpret it as an inverted head and shoulders bottom
bouncing off the ichimoku cloud
hammer and doji candlesticks









normal chart




log chart





Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist